![Torsten Mau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Torsten Mau
Director/Board Member at Boehringer Ingelheim Deutschland GmbH
Network origin in Torsten Mau first degree
Entity | Entity type | Industry | |
---|---|---|---|
Boehringer Ingelheim Deutschland GmbH
![]() Boehringer Ingelheim Deutschland GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Deutschland GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Martin Beck and Sabine Nikolaus.
17
| Subsidiary | Financial Conglomerates | 17 |
Boehringer Ingelheim International GmbH
![]() Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.
4
| Subsidiary | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Torsten Mau via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Boehringer Ingelheim GmbH
![]() Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
KWS SAAT SE & CO. KGAA | Miscellaneous Commercial Services | Director/Board Member | |
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Okairos AG
![]() Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Ekosem-Agrar AG
![]() Ekosem-Agrar AG Agricultural Commodities/MillingProcess Industries Ekosem-Agrar AG is a holding company, with interests in the the production and processing of animal and vegetable agricultural products. Its products includes diary and diary related products, agriculture, seed production and breeding, suckler cow husbandry and organic agriculture. The firm grows grain, potatoes, peas, sunflowers, sugar beets, soybeans, fodder, and other crops. The company was founded by Stefan Dürr in 1994 and is headquartered in Walldorf, Germany. | Agricultural Commodities/Milling | Director/Board Member | |
Ehrmann AG
![]() Ehrmann AG Food: Meat/Fish/DairyConsumer Non-Durables Ehrmann AG manufactures and distributes dairy products. It offers almighurt, grand dessert, orchard, dreams, lacto zero, and natural products. The company was founded by Alois Ehrmann in 1920 and is headquartered in Oberschönegg, Germany. | Food: Meat/Fish/Dairy | Director of Finance/CFO | |
Boehringer Ingelheim Pharma GmbH & Co., KG
![]() Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach. | Biotechnology | Chief Executive Officer Chairman Chief Executive Officer | |
Boehringer Ingelheim Ltd.
![]() Boehringer Ingelheim Ltd. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Ltd. develops, manufactures, and distributes pharmaceutical products. It offers products for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, Parkinson's disease, arthritis, and pain relief in cancer. The company was founded in 1885 and is headquartered in Bracknell, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Boehringer Ingelheim AB
![]() Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boehringer Ingelheim RCV GmbH & Co. KG
![]() Boehringer Ingelheim RCV GmbH & Co. KG BiotechnologyHealth Technology Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria. | Biotechnology | Director/Board Member Director/Board Member | |
Profunda Verwaltungs GmbH
![]() Profunda Verwaltungs GmbH Investment ManagersFinance Part of Profunda Verwaltungs GmbH & Co. KG, the German company provides asset management services. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Hubertus von Baumbach, Christoph Gauger. | Investment Managers | Chief Executive Officer | |
Boehringer Ingelheim Europe GmbH
![]() Boehringer Ingelheim Europe GmbH Pharmaceuticals: MajorHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Europe GmbH is a German company that manufactures basic pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler and Martin Schwarz. The company was founded in 1990. | Pharmaceuticals: Major | Chief Executive Officer | |
Boehringer Ingelheim (Venture Capital)
![]() Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts. | Investment Managers | President | |
Eyevensys SAS
![]() Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Boehringer Ingelheim Vetmedica GmbH
![]() Boehringer Ingelheim Vetmedica GmbH BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Vetmedica GmbH is a German company dedicated to the research and development of products related to animal health. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Dana Leskova, Stephan Günther Dolle. | Biotechnology | Chief Executive Officer | |
Boehringer Ingelheim Corporate Center GmbH
![]() Boehringer Ingelheim Corporate Center GmbH Real Estate DevelopmentFinance Founded in 2016, Boehringer Ingelheim Corporate Center GmbH is a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The company is based in Ingelheim am Rhein, Germany and specializes in leasing real estate properties. | Real Estate Development | Chief Executive Officer Chief Executive Officer | |
BIOTHERAX biochemisch-pharmazeutische GmbH
![]() BIOTHERAX biochemisch-pharmazeutische GmbH Pharmaceuticals: MajorHealth Technology BIOTHERAX biochemisch-pharmazeutische GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Michael Schmelmer, Martin Beck. | Pharmaceuticals: Major | Chief Executive Officer | |
Boehringer Ingelheim Finanzierungs GmbH
![]() Boehringer Ingelheim Finanzierungs GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Finanzierungs GmbH is a financial services provider. The company is based in Ingelheim am Rhein, Germany. The CEOs are Jochen Gann, Martin Schwarz. The German company was founded in 1968. | Financial Conglomerates | Chief Executive Officer | |
Boehringer Ingelheim Animal Health Japan Holding GmbH
![]() Boehringer Ingelheim Animal Health Japan Holding GmbH Pharmaceuticals: MajorHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health Japan Holding GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Frank Hübler, Martin Schwarz. | Pharmaceuticals: Major | Chief Executive Officer | |
Boehringer Ingelheim Animal Health China Participations GmbH
![]() Boehringer Ingelheim Animal Health China Participations GmbH Agricultural Commodities/MillingProcess Industries Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health China Participations GmbH provides veterinary services. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler, Martin Schwarz. The German company was founded in 2019. | Agricultural Commodities/Milling | Chief Executive Officer | |
Cobepa SA
![]() Cobepa SA Financial ConglomeratesFinance Cobepa SA is an investment holding Belgian company. The company is based in Brussels, Belgium. The company was founded in 1957. The CEO is Jean-Marie Laurent Josi. | Financial Conglomerates | Director/Board Member |
Statistics
International
Germany | 16 |
United States | 2 |
Switzerland | 2 |
United Kingdom | 2 |
Sweden | 2 |
Sectoral
Health Technology | 13 |
Finance | 6 |
Commercial Services | 3 |
Process Industries | 3 |
Consumer Non-Durables | 2 |
Operational
Director/Board Member | 21 |
Chief Executive Officer | 20 |
Corporate Officer/Principal | 7 |
Chairman | 3 |
Director of Finance/CFO | 2 |
Most connected contacts
- Stock Market
- Insiders
- Torsten Mau
- Company connections